Prestige Scientific completes Chief Medical Officer search

Prestige Scientific completes Chief Medical Officer search

Milford MA. – August 2020 Prestige Scientific announces the successful completion of a search for Chief Medical Officer for our rapidly growing biotechnology partner pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology.

This critical hire has extensive expertise in developing bispecific immuno-oncology agents, as well as toxin conjugate therapeutics for cancer and other serious diseases. They will be responsible for designing and driving clinical development plans for our client’s pipeline candidates, all of which currently represent possible first-in-class or best-in-class therapies.

Client Objectives: Our client’s mission is to continue the development of their novel class of medicines for diseases that are underserved by existing therapeutics.

Project: Prestige Scientific outlined search objectives along with the senior management team. An international search was conducted, and senior Executives from across the United States, UK, Germany, and Switzerland were identified for consideration. After only 10 days Prestige submitted the candidate who would ultimately be hired. A hire was made after 68 days from initiation of the search project.

About Prestige Scientific: Prestige Scientific provides our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own while overcoming challenges and adhering to critical timelines. This systematic approach has proven to decrease our client’s time-to-fill while increasing hiring accuracy. On average our executive searches are completed in 59 days, with the eventual hire presented to the client by the 9th day of the search, with a success rate of 99.7%. Prestige Scientific team members specialize by Practice Area and are deeply anchored in each discipline.